Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Provides SOLiD Platform for University of Strasbourg's Genomax Project

Premium

Life Technologies said last month that its SOLiD platform is "supporting" the Genomax project of the University of Strasbourg, France, to study diseases such as diabetes, obesity, asthma, and arterial hypertension.

Genomax, funded with €1.1 million ($1.4 million) from the University of Strasbourg, the regional government, and others, is part of Biomax, a translational biobank project to enable the storage and analysis of thousands of human samples.

According to Seiamak Bahram, head of Genomax and a professor of immunology at Strasbourg University Hospital, "hundreds" of blood samples have been sequenced on the SOLiD platform, providing "an invaluable insight into the most common diseases."

Life Tech's director of digital PCR in Europe, Herve Pouzoullic, said in a statement that the company "is proud to be supplying" its products to Genomax, including its SOLiD sequencing and Open Array Real-Time PCR platforms.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more